82 related articles for article (PubMed ID: 9122277)
1. [Lipoamino acids and lipopeptides as potential 5- and 12-lipoxygenase inhibitors].
Presenz P
Pharmazie; 1997 Feb; 52(2):164-5. PubMed ID: 9122277
[No Abstract] [Full Text] [Related]
2. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
3. [Pyrano[3,4-c]quinolines from 1-desaza--oxa-nifedipine].
Görlitzer K; Trittmacher J; Jones PG; Frohberg P; Drutkowski G
Pharmazie; 2003 Aug; 58(8):539-42. PubMed ID: 12967028
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
Richwien A; Wurm G
Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
[TBL] [Abstract][Full Text] [Related]
5. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
Deigner HP; Wolf G; Ohlenmacher U; Reichling J
Arzneimittelforschung; 1994 Aug; 44(8):956-61. PubMed ID: 7945541
[TBL] [Abstract][Full Text] [Related]
6. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Frohberg P; Drutkowski G
Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
[TBL] [Abstract][Full Text] [Related]
7. Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation.
Safayhi H; Sabieraj J; Sailer ER; Ammon HP
Planta Med; 1994 Oct; 60(5):410-3. PubMed ID: 7997466
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase inhibitors: convenient synthesis of 4-[3-(4-heterocyclylphenylthio)phenyl]-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide analogues.
Mano T; Stevens RW; Okumura Y; Kawai M; Okumura T; Sakakibara M
Bioorg Med Chem Lett; 2005 May; 15(10):2611-5. PubMed ID: 15863327
[TBL] [Abstract][Full Text] [Related]
11. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
Schneider I; Bucar F
Phytother Res; 2005 Feb; 19(2):81-102. PubMed ID: 15852496
[TBL] [Abstract][Full Text] [Related]
12. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
Ghosh J
Biochem Biophys Res Commun; 2004 Mar; 315(3):624-35. PubMed ID: 14975747
[TBL] [Abstract][Full Text] [Related]
13. Diphyllin acetylapioside, a 5-lipoxygenase inhibitor from Haplophyllum hispanicum.
Prieto JM; Giner RM; Recio Mf MC; Schinella G; Máñez S; Ríos JL
Planta Med; 2002 Apr; 68(4):359-60. PubMed ID: 11988863
[TBL] [Abstract][Full Text] [Related]
14. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
15. 5-Methylflavasperone and rhamnetin from Guiera senegalensis and their antioxidative and 5-lipoxygenase inhibitory activity.
Bucar F; Resch M; Bauer R; Burits M; Knauder E; Schubert-Zsilavecz M
Pharmazie; 1998 Dec; 53(12):875-8. PubMed ID: 9879572
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukotriene production by inhibitors of lipoxygenation.
Garland LG; Hodgson ST
Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():33-48. PubMed ID: 7771347
[No Abstract] [Full Text] [Related]
17. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
18. Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study.
Chou DS; Lee JJ; Hsiao G; Hsieh CY; Tsai YJ; Chen TF; Sheu JR
J Agric Food Chem; 2007 Feb; 55(3):649-55. PubMed ID: 17263456
[TBL] [Abstract][Full Text] [Related]
19. Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.
Cho H; Ueda M; Tamaoka M; Hamaguchi M; Aisaka K; Kiso Y; Inoue T; Ogino R; Tatsuoka T; Ishihara T
J Med Chem; 1991 Apr; 34(4):1503-5. PubMed ID: 2016727
[No Abstract] [Full Text] [Related]
20. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
